_the-use-of-sodium-glucose-cotransporter-2-sglt2-inhibitors-in-stemi-weekly-research-conference-preview-1.jpg "The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference from sgkt2 Video Screenshot Preview 1")
Gallery_the-use-of-sodium-glucose-cotransporter-2-sglt2-inhibitors-in-stemi-weekly-research-conference-preview-3.jpg "The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference from sgkt2 Video Screenshot Preview 3")
Gallery_the-use-of-sodium-glucose-cotransporter-2-sglt2-inhibitors-in-stemi-weekly-research-conference-preview-hqdefault.jpg "The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference from sgkt2 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 49 minutes 58 seconds
👁 View: 749 times
Play Audio:👁 View: 749 times
Description:
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_how-does-dapagliflozin-work-understanding-sglt2-inhibitors.webp "Zero To Finals")
_when-should-we-use-sglt2-inhibitors.webp "The France Foundation")
_sglt2-inhibitors-in-chronic-kidney-disease.webp "Harvard Medical School Continuing Education")
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.webp "Harvard Medical School Continuing Education")
_best-practices-for-starting-sglt2-inhibitors-in-hfpef-treatment.webp "Medscape")
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.webp "Fresenius Medical Care North America")
⏲ 15 minutes 35 seconds 👁 896
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.webp "Mayo Proceedings")
⏲ 5 minutes 7 seconds 👁 171
_introduction-to-sglt2-inhibition.webp "Boehringer Ingelheim")
_how-does-dapagliflozin-work-understanding-sglt2-inhibitors.jpg)
_when-should-we-use-sglt2-inhibitors.jpg)
_sglt2-inhibitors-in-chronic-kidney-disease.jpg)
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.jpg)
_best-practices-for-starting-sglt2-inhibitors-in-hfpef-treatment.jpg)
_field-notes-ep-19-124-slowing-down-progression-of-ckd-sglt2-inhibitors-with-dr-robert-kossmann.jpg)
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.jpg)
_introduction-to-sglt2-inhibition.jpg)
![[+]](/images/menu.gif){kind=small}